Target intelligence / Profile preview

Mitochondrial copper pool

Molecular classification
Metal ion, Metabolic pool, Enzyme cofactor
01

Overview

The mitochondrial copper pool refers to the regulated concentration of copper ions within the mitochondria, which serves as an essential cofactor for cytochrome c oxidase (COX) in the electron transport chain [1]. This pool is maintained by specific transporters and chaperones to prevent the formation of reactive oxygen species while ensuring adequate supply for aerobic respiration [1]. Recent discoveries have highlighted the mitochondrial copper pool as the focal point for cuproptosis, a form of regulated cell death where excess copper binds directly to lipoylated components of the tricarboxylic acid (TCA) cycle, such as dihydrolipoamide S-acetyltransferase (DLAT) [2]. This interaction leads to the aggregation of lipoylated proteins and proteotoxic stress, providing a novel therapeutic vulnerability in cancer cells that rely heavily on mitochondrial metabolism [2, 3]. Pharmacological intervention typically involves copper ionophores to induce cuproptosis or copper chelators to manage overload diseases like Wilson's disease or to limit tumor growth and angiogenesis [4, 5]. [1] Cobine et al. (2021) BBA Mol Cell Res; [2] Tsvetkov et al. (2022) Science; [3] Nagai et al. (2012) Free Radic Biol Med; [4] Brewer (2005) Front Biosci; [5] Lutsenko (2010) Biochem Soc Trans.

Other names
Mitochondrial copperIntramitochondrial copper poolLabile mitochondrial copper poolMitochondrial Cu pool
02

Mechanism of action

Copper ionophores (e.g., elesclomol) facilitate the transport of copper into the mitochondrial matrix to induce cuproptosis via lipoylated protein aggregation [2, 3]. Copper chelators (e.g., tetrathiomolybdate) sequester copper ions to prevent toxicity or inhibit copper-dependent enzymes [4, 5].

03

Biological functions

Mitochondrial respirationCuproptosisRedox homeostasisEnzyme catalysis
04

Disease associations

CancerWilson diseaseMenkes diseaseNeurodegenerative disease
05

Safety considerations

Systemic copper deficiencyHepatotoxicityNeurotoxicityAnemiaGastrointestinal distress
06

Interacting drugs

Elesclomol

4 more in the full profile.

07

Biomarkers

Ferredoxin 1 (FDX1) expressionLipoylated dihydrolipoamide S-acetyltransferase (DLAT) levelsSerum ceruloplasminUrinary copper excretion

Beyond the preview

Go deeper on Mitochondrial copper pool.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial copper pool.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call